These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39023341)

  • 1. Letter to the Editor: Rifamycin SV MMX was superior to placebo, but was the comparison appropriate?
    Zhu M; Wang Z; Tian X; Zhang Y
    Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39023341
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifamycin SV MMX
    Hoy SM
    Clin Drug Investig; 2019 Jul; 39(7):691-697. PubMed ID: 31172447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifamycin SV MMX for the treatment of traveler's diarrhea.
    Lin SW; Lin CJ; Yang JC
    Expert Opin Pharmacother; 2017 Aug; 18(12):1269-1277. PubMed ID: 28697313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
    Steffen R; Jiang ZD; Gracias Garcia ML; Araujo P; Stiess M; Nacak T; Greinwald R; DuPont HL
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30462260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
    DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
    J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile.
    Farrell DJ; Putnam SD; Biedenbach DJ; Moro L; Bozzella R; Celasco G; Jones RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):992-6. PubMed ID: 21149623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers.
    Di Stefano AF; Rusca A; Loprete L; Dröge MJ; Moro L; Assandri A
    Antimicrob Agents Chemother; 2011 May; 55(5):2122-8. PubMed ID: 21402860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of rifamycin SV combined with oxytetracycline in the treatment of caseous lymphadenitis in sheep.
    Senturk S; Temizel M
    Vet Rec; 2006 Aug; 159(7):216-7. PubMed ID: 16905739
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis.
    Marchesoni A; Sinigaglia L; Ranza R; Varenna M; Battafarano N; Tosi S
    Scand J Rheumatol; 1993; 22(4):194-8. PubMed ID: 8356413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-oxidant action of superoxide dismutase in the autoxidation of rifamycin SV.
    Michelson AM
    Free Radic Res Commun; 1986; 1(3):185-8. PubMed ID: 2577735
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of rifamycins with mammalian nucleic acid polymerizing enzymes.
    Sethi VS; Okano P
    Biochim Biophys Acta; 1976 Dec; 454(2):230-47. PubMed ID: 63293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster.
    Bruni L; Califano A; De Angelis G; Montagnani A; Pisani M; Pezzarossa G; Pozzo G; Reali D; Rebora A; Zanca A
    J Int Med Res; 1980; 8(1):1-6. PubMed ID: 6987112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.
    Caruso I; Montrone F; Fumagalli M; Patrono C; Santandrea S; Gandini MC
    Ann Rheum Dis; 1982 Jun; 41(3):232-6. PubMed ID: 7046652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparative Insight on the Newly Emerging Rifamycins: Rifametane, Rifalazil, TNP-2092 and TNP-2198.
    Nazli A; He DL; Xu H; Wang ZP; He Y
    Curr Med Chem; 2022; 29(16):2846-2862. PubMed ID: 34365945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile.
    Huang JS; Jiang ZD; Garey KW; Lasco T; Dupont HL
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2690-3. PubMed ID: 23545528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide.
    Bruni L; Tagliapietra G; Innocenti P
    J Int Med Res; 1984; 12(4):255-60. PubMed ID: 6381169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply.
    Steffen R; DuPont HL
    J Travel Med; 2019 May; 26(3):. PubMed ID: 30848824
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
    Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV.
    Kukiełka E; Cederbaum AI
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):361-7. PubMed ID: 7733870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.